comparemela.com

Latest Breaking News On - மகிழ்ச்சி பார்மா - Page 11 : comparemela.com

Remdesivir shortage concerns take a global turn - The Hindu BusinessLine

Remdesivir shortage concerns take a global turn April 19, 2021 Public health voices, former noble laureates have called for Covid-19-linked vaccines to be free of IP restrictions   -  REUTERS Public health voices, former noble laureates have called for Covid-19-linked vaccines to be free of IP restrictions   -  REUTERS× Jharkhand CM seeks to source from Bangladesh company Jharkhand Chief Minister Hemant Soren’s efforts to source antiviral Remdesivir from Bangladesh-based Beximco Pharmaceuticals has given the procurement issue a whole new dimension. Soren said he had written to the Centre regarding his efforts to procure the drug from Beximco, as local supplies fell short. The State was willing to procure 50,000 vials at $1 million, he said, adding that it had got a quotation for the same from Beximco. The State’s need was for 76,640 vials, but they had got just 8,038 vials, he said, in a letter on Sunday.

remdesivir: Jubilant Pharmova surges as company develops Remdesivir oral form

MUMBAI: Jubilant Pharma subsidiary Jubilant Pharmova s shares soared as much as 10 per cent on Monday after the company announced that it haD developed an oral version of critical Covid-19 treatment drug Remdesivir. “Jubilant has sought authorisation for additional studies for this novel oral formulation from the Drug Controller General of India. Jubilant is hoping to provide an affordable, more convenient, easy-to-administer and potentially effective treatment option for Covid-19 patients,” the company said in an exchange filing. Remdesivir has been in high demand in the country in the wake of surging Covid-19 infections over the past one month. Hospitals and pharmacists in major cities have reported acute shortage of the drug due to supply constraints and alleged hoarding.

Jubilant arm develops oral Remdesivir to treat Covid

Jubilant arm develops oral Remdesivir to treat Covid ​ By IANS | ​ 4 Views How remdesivir can save lives in nations with lower hospital capacity.. Image Source: IANS News Bengaluru, April 19 : Drug maker Jubilant Pharmova s subsidiary Jubilant Pharma on Monday said it has developed an oral formulation of remdesivir for non-invasive treatment of coronavirus. We have completed safety trials of the oral formulation of remdesivir by administering it to animals and human volunteers in the country, said the company in a statement here. The Noida-based drug firm has a production plant near Mysuru. The company has applied to regulator, the Drug Controller General of India for authorisation to conduct additional trials of the novel formulation.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.